top of page
Rocky Mountain Discussion Group 2023 Annual Meeting
Rocky Mountain Discussion Group 2023 Annual Meeting
Sep 29, 2023, 11:00 AM – 3:30 PM MDT
Annual Virtual Event
Home: Event Details

American Association of Pharmaceutical Scientists, Rocky Mountain Discussion Group is just around the corner, and we are so excited for you to see what’s in store. We’ve brought together a unique and inspiring group of speakers, with a schedule full of engaging events and career round table session. Don’t miss out!

Home: Welcome

Program Schedule

Conference begins at 10:00 AM PDT / 11:00 AM MDT

We’re happy to share the full schedule for American Association of Pharmaceutical Scientists, Rocky Mountain Discussion Group. Check out the information below to see what’s planned and when each activity is taking place.


 11:00 AM MDT 

Megalin/Cubilin: Role in kidney endocytosis of proteins and peptides

Mark Bryniarski, Ph.D.

Principal Scientist, Amgen 

11:10 AM - 12:05 PM MDT

Microbiome-mediated effects of natural products on neurotransmitter-related molecular networks and the metabolome

Nichole Reisdorph, Ph.D.

Professor, Mass Spectrometry Core Director, University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences

12:05 - 12:35 PM MDT

Looking Beyond Kinact:
The Importance of Understanding The Mechanisms Behind CYP3A MBI

Larry Wienkers, Ph.D.

Principal Scientist, Weinkers Consulting, LLC

12:35 - 1:00 PM MDT

Career Round-table Group Discussion
"Academia and industry careers: breaking through the virtual wall."

TABLE: Mark Bryniarski, Ph.D., Nichole Reisdorph Ph.D., and Larry Wienkers Ph.D.
MODERATOR: Jed Lampe, Ph.D.

1:00 - 2:00 PM MDT


2:00-3:00 PM MDT

Inhibition of fetal CYP3A7 by HCV antiviral inhibitors
Hannah Work

Lampe Lab, University of Colorado

2:00 - 2:12 PM MDT

Drugs during pregnancy: mapping a dynamic frontier

Rachel Hudson, Ph.D.

Division of Clinical Pharmacology, University of Utah

2:12 - 2:24 PM MDT

Effect of cimetidine on metformin pharmacokinetics and endogenous metabolite levels in rats

Anoud Ailabouni

Prasad Lab, Washington State University

2:24 - 2:36 PM MDT

Manufacturing Microneedles as Novel Vaccination Strategy against Malaria

Aiden Lebya
Muttil Lab, University of New Mexico

2:36 - 2:48 PM MDT

Closing Remarks

2:48 - 3:00 PM MDT

Home: Schedule

Our Speakers

We’re proud to feature a list of prominent speakers who are at the forefront of their fields. These professionals are always eager to share their knowledge and inspire others. Don’t miss out - register today.


Mark Bryniarski, Ph.D.

Principal Scientist, Amgen

Mark obtained an MS in Pharmacology and PhD in Pharmaceutical Sciences from the University at Buffalo. After a one-year post-doctoral position in the department of Pharmaceutical Sciences at Buffalo, he was appointed as a Research Assistant Professor in the Spring of 2020. His work centered on proximal tubule protein reabsorption: the role of the protein transporter megalin (LRP2) in the renal disposition of protein therapeutics and the impact of diabetic kidney disease on megalin expression and function. In the summer of 2020, Mark joined the PKDM department at Amgen where he is currently a Principal Scientist. His primary research aim has been to characterize and quantify the target-independent clearance pathways of biologics. His work involves the development and application of novel cell-based methodologies, such as the utilization of microphysiologic systems to better define the ADME of various protein modalities.

Larry Wienkers.jpg

Larry Wienkers, Ph.D.

Larry C. Wienkers received his BS in Chemistry and Biology in 1986 and his MS in Chemistry in 1988 from Western Washington University. He then went on and earned his Ph.D. in Medicinal Chemistry from University of Washington in 1993 under the direction of Dr William F. Trager. Upon graduating, he did postdoctoral work in the department of Drug Metabolism at the Upjohn Company and subsequently joined the company as a Research Scientist in 1995. In 1998 Larry became Director of Drug Metabolism Enabling Technologies at Pharmacia & Upjohn and in 2002 became Executive Director of Pharmacokinetics, Dynamics and Metabolism at Pfizer, St Louis MO. In 2004 Larry moved to Amgen to start a PKDM group in Seattle, was promoted to Vice President in 2014 and subsequently retired from his role as Global Head of the department of Pharmacokinetics and Drug Metabolism in 2018. Larry is an American Association of Pharmaceutical Scientists (AAPS) Fellow (2012); was the recipient of the University of Washington, School of Pharmacy Distinguished Alumni Award in Pharmaceutical Science and Research Award (2014) and served as Chair of American Society of Pharmacology and Experimental Therapeutics Division of Drug Metabolism (2015).  In addition to consulting, he serves as an Affiliate Faculty in the Department of Medicinal Chemistry at the University of Washington and to date has published over 100 peer reviewed manuscripts and book chapters.

Nichole Reisdorph.jpg

Nichole Reisdorph Ph.D.

Dr. Nichole Reisdorph is Professor in the Department of Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus and is Scientific Director of the Skaggs School of Pharmacy Mass Spectrometry Facility.  As a Core Director, Dr. Reisdorph collaborates on a range of projects spanning from epilepsy and diabetes to respiratory disease and aging; giving her a broad perspective on several human diseases.  The major emphasis of her own research program is on “Nutrimetabolomics”, a relatively new field that represents the intersection between nutrition studies and metabolomics. Dr. Reisdorph’s team takes a novel approach to biomarker discovery, which is based on first understanding the chemical composition of foods and plants.  In addition to discovering dietary biomarkers, Dr. Reisdorph is using germ free and humanized mice to understand the role of the microbiome in metabolizing specific foods and food compounds.  This research aims to understand how host:microbiome metabolism of  foods and plants, such as green tea and Cannabis, affect health outcomes such as depression and anxiety.  This is achieved through behavioral studies and understanding the association of food-derived metabolites with levels of neurotransmitters such as dopamine and serotonin.

Home: Speakers

Student/Trainee Speakers

Be Wild !_edited.jpg

Hannah Work
Lampe Lab, University of Colorado

Inhibition of fetal CYP3A7 by HCV antiviral inhibitors

Rachel Hudson.jpg

Rachel Hudson, Ph.D.
Division of Clinical Pharmacology, University of Utah

Drugs during pregnancy: mapping a dynamic frontier

Anoud Ailabouni.jpg

Anoud Ailabouni, MS
Prasad Lab, Washington State University

Dual-Drug Antibody-Drug Conjugates for Potentiated Therapy

Aiden Leyba.jpg

Aiden Leyba, MS 
Muttil Lab, University of New Mexico

Next generation vaccines:
TLR7/8 agonist self-adjuvanted anti-fentanyl vaccine enhances protection from fentanyl challenge

Home: Team Members

RMDG Steering Committee

Jed Lampe, PhD
Bhagwat Prasad, PhD
Casey Sayre, PharmD, PhD
Deepa Rao, PhD
Erica Woodahl, PhD
Joseph Rower, PhD
Joe Zolnerciks, PhD
John Clarke, PhD
John Harrelson, PhD
Jonathan Constance, PhD
Kathleen Job, PhD
Venkata (Kash) Yellepeddi, PhD, RPh
Lisa Davis, PharmD
Michael Espiritu, PhD
Melanie Joy, PharmD, PhD
Pavan Muttil, PhD
Randy Adachi, PhD
Yvonne Lin, PhD

Meeting Host

Jed Lampe, PhD

Home: List

Our Sponsors

We are grateful to our sponsors who have helped the RMDG to sustain scientific programming of the highest quality for the past years and many more to come!

  • West Pharmaceuticals

  • University of Montana

  • University of Utah, Department of Pediatrics, Clinical Pharmacology

  • Skaggs School of Pharmacy and Pharmaceutical Science, University of Colorado

  • University of New Mexico, College of Pharmacy, Department of Pharmaceutical Sciences

  • University of Washington

  • Sekisui Xenotech

  • Biomedical & Pharmaceutical Sciences

  • Daikyo

  • Seattle Genetics

  • Promega

  • Hertz

  • Solvo Biotechnology

  • Roseman University of Health Sciences

  • Nelson Laboratories

  • Vitro Biopharma

  • Activis

  • PharmaClean Group

  • Impact Analytical

  • WordCraft

  • Wasatch Scientific

Home: Text

Get in Touch

  • LinkedIn

Thanks for submitting!

Home: Contact

RMDG Past Meetings

Precision medicine in drug development and pharmacotherapy

August 5, 2022

Keynote Speaker: Kenneth Thummel, PhD
Seattle, WA (virtual)

Advances and Innovation in Respiratory Drug Delivery

December 10, 2021

Keynote Speaker: Heidi Mansour, PhD, RPh
Tucson, AZ  (virtual)

Pharmaceutical Science in the Next Decade: Pioneering Advances in Human Health

November 13, 2020

Keynote Speaker: Hamid Ghandehari, PhD 
Salt Lake City, Utah (virtual)

Exploring Biological and Mechanistic Variability in Pharmaceutical Discovery

July 26-27, 2019

Keynote Speaker: Emily Scott, PhD 
Portland, Oregon

Expanding the Frontiers of Pharmaceutical Sciences

June 12-13, 2018

Seattle, Washington

Insights from the Past...Shaping the Future: Research at the Intersection of Pharmaceutics & Toxicology

September 20-22, 2017

Keynote Speakers: Anthony J. Hickey, PhD and Lois D. Lehman-McKeeman, PhD
Albuquerque, New Mexico

Addressing Health Challenges through Research in Pharmaceutical Science

August 5-6, 2016

Keynote Speaker: Leslie Benet, PhD
Las Vegas, Nevada

Pharmaceutical Sciences: From Discovery to Translation

September 23, 2015

Breckenridge, Colorado

Advancing Pharmaceutical Science to Improve Health

August 13, 2014

Missoula, Montana

Perspectives in Translational and Clinical Researchium

August 5, 2013

Salt Lake City, Utah

green and blue medication pill_edited.jpg
Home: Past Events
bottom of page